{"id":353168,"date":"2025-08-28T08:01:18","date_gmt":"2025-08-28T08:01:18","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-united-therapeutics-corporation\/"},"modified":"2025-08-28T08:01:18","modified_gmt":"2025-08-28T08:01:18","slug":"how-to-buy-united-therapeutics-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-353168","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu United Therapeutics Corporation (UTHR) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu United Therapeutics Corporation (UTHR)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu United Therapeutics Corporation (UTHR) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu United Therapeutics Corporation (UTHR)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i n\u0103m 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i n\u0103m 2025."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty kh\u00f4ng ch\u1ec9 c\u1ee9u s\u1ed1ng con ng\u01b0\u1eddi m\u00e0 c\u00f2n c\u00f3 th\u1ec3 gi\u00fap t\u0103ng tr\u01b0\u1edfng t\u00e0i s\u1ea3n c\u1ee7a b\u1ea1n? United Therapeutics Corporation k\u1ebft h\u1ee3p c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn v\u1edbi hi\u1ec7u su\u1ea5t t\u00e0i ch\u00ednh v\u1eefng ch\u1eafc. \u0110\u00e2y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m th\u00f4ng th\u01b0\u1eddng\u2014m\u00e0 l\u00e0 m\u1ed9t c\u00f4ng ty ti\u00ean phong trong s\u1ea3n xu\u1ea5t c\u01a1 quan v\u00e0 chuy\u1ec3n \u0111\u1ed5i \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ph\u1ed5i. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao UTHR x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng y h\u1ecdc n\u00e0y.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty kh\u00f4ng ch\u1ec9 c\u1ee9u s\u1ed1ng con ng\u01b0\u1eddi m\u00e0 c\u00f2n c\u00f3 th\u1ec3 gi\u00fap t\u0103ng tr\u01b0\u1edfng t\u00e0i s\u1ea3n c\u1ee7a b\u1ea1n? United Therapeutics Corporation k\u1ebft h\u1ee3p c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn v\u1edbi hi\u1ec7u su\u1ea5t t\u00e0i ch\u00ednh v\u1eefng ch\u1eafc. \u0110\u00e2y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu d\u01b0\u1ee3c ph\u1ea9m th\u00f4ng th\u01b0\u1eddng\u2014m\u00e0 l\u00e0 m\u1ed9t c\u00f4ng ty ti\u00ean phong trong s\u1ea3n xu\u1ea5t c\u01a1 quan v\u00e0 chuy\u1ec3n \u0111\u1ed5i \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ph\u1ed5i. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao UTHR x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng y h\u1ecdc n\u00e0y."},"body_html":"<h2>\ud83d\udcc8 Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu United Therapeutics: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 28 th\u00e1ng 8 n\u0103m 2025, United Therapeutics Corporation (UTHR) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>305,35 USD<\/strong>\u2014m\u1ed9t m\u1ee9c quan tr\u1ecdng \u0111\u1ea1i di\u1ec7n cho c\u1ea3 c\u01a1 h\u1ed9i v\u00e0 s\u1ef1 th\u1eadn tr\u1ecdng \u0111\u1ed1i v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0. Nh\u01b0ng h\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: <strong>Th\u00e1ng 9 n\u0103m 2025 c\u00f3 th\u1ec3 thay \u0111\u1ed5i m\u1ecdi th\u1ee9<\/strong> \u0111\u1ed1i v\u1edbi c\u1ed5 phi\u1ebfu n\u00e0y.<\/p> <p>K\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng TETON 2 s\u1eafp t\u1edbi v\u1ec1 treprostinil d\u1ea1ng kh\u00ed dung trong b\u1ec7nh x\u01a1 ph\u1ed5i v\u00f4 c\u0103n (IPF) c\u00f3 th\u1ec3 l\u00e0 b\u01b0\u1edbc ngo\u1eb7t l\u1edbn. C\u00e1c nh\u00e0 ph\u00e2n t\u00edch t\u1eeb <a href=\"https:\/\/finimize.com\/content\/united-therapeutics-puts-big-bets-on-tyvasos-trial-results\">Finimize<\/a> cho r\u1eb1ng k\u1ebft qu\u1ea3 t\u00edch c\u1ef1c c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu t\u0103ng m\u1ea1nh, trong khi <a href=\"https:\/\/www.ainvest.com\/news\/united-therapeutics-september-ipf-data-readout-strategic-catalyst-shareholder-2508\/\">AI Invest<\/a> g\u1ecdi \u0111\u00e2y l\u00e0 \"ch\u1ea5t x\u00fac t\u00e1c chi\u1ebfn l\u01b0\u1ee3c cho gi\u00e1 tr\u1ecb c\u1ed5 \u0111\u00f4ng.\"<\/p> <h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng L\u1ee3i Nhu\u1eadn L\u1ecbch S\u1eed<\/h3> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><th>Ph\u00e2n T\u00edch<\/th><\/tr> <\/thead> <tbody> <tr><td>30 th\u00e1ng 7, 2025<\/td><td>L\u1ee3i nhu\u1eadn Q2<\/td><td>312,00 USD<\/td><td>-2,1% (b\u1ecf l\u1ee1 \u01b0\u1edbc t\u00ednh EPS)<\/td><td>T\u0103ng tr\u01b0\u1edfng doanh thu nh\u01b0ng EPS g\u00e2y th\u1ea5t v\u1ecdng<\/td><\/tr> <tr><td>30 th\u00e1ng 4, 2025<\/td><td>L\u1ee3i nhu\u1eadn Q1<\/td><td>298,50 USD<\/td><td>+4,5% (v\u01b0\u1ee3t \u01b0\u1edbc t\u00ednh)<\/td><td>Hi\u1ec7u su\u1ea5t s\u1ea3n ph\u1ea9m m\u1ea1nh m\u1ebd<\/td><\/tr> <tr><td>26 th\u00e1ng 2, 2025<\/td><td>L\u1ee3i nhu\u1eadn Q4 2024<\/td><td>290,75 USD<\/td><td>+3,2% (k\u1ebft qu\u1ea3 v\u1eefng ch\u1eafc)<\/td><td>M\u00f4 h\u00ecnh t\u0103ng tr\u01b0\u1edfng \u1ed5n \u0111\u1ecbnh<\/td><\/tr> <tr><td>29 th\u00e1ng 10, 2024<\/td><td>L\u1ee3i nhu\u1eadn Q3 2024<\/td><td>285,25 USD<\/td><td>+1,9% (\u0111\u1ea1t k\u1ef3 v\u1ecdng)<\/td><td>Hi\u1ec7u su\u1ea5t \u1ed5n \u0111\u1ecbnh<\/td><\/tr> <\/tbody> <\/table> <p>M\u00f4 h\u00ecnh cho th\u1ea5y UTHR th\u01b0\u1eddng tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng 2-5% quanh c\u00e1c k\u1ef3 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn, nh\u01b0ng k\u1ebft qu\u1ea3 TETON 2 th\u00e1ng 9 c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t bi\u1ebfn \u0111\u1ed9ng l\u1edbn h\u01a1n t\u1eeb 15-25% d\u1ef1a tr\u00ean c\u00e1c s\u1ef1 ki\u1ec7n ch\u1ea5t x\u00fac t\u00e1c sinh h\u1ecdc l\u1ecbch s\u1eed.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng v\u00e0 Ph\u00e2n T\u00edch Xu H\u01b0\u1edbng<\/h2> <p>United Therapeutics \u0111\u00e3 tr\u1ea3i qua m\u1ed9t qu\u1ef9 \u0111\u1ea1o bi\u1ebfn \u0111\u1ed9ng nh\u01b0ng cu\u1ed1i c\u00f9ng l\u00e0 t\u00edch c\u1ef1c trong s\u00e1u th\u00e1ng qua:<\/p> <p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 290,75 USD - K\u1ebft qu\u1ea3 Q4 m\u1ea1nh m\u1ebd t\u1ea1o n\u1ec1n t\u1ea3ng<br\/> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 302,40 USD - Th\u1ecb tr\u01b0\u1eddng k\u1ef3 v\u1ecdng l\u1ee3i nhu\u1eadn Q1<br\/> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 312,00 USD - T\u0103ng sau b\u00e1o c\u00e1o v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<br\/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 308,25 USD - Ch\u1ed1t l\u1eddi v\u00e0 c\u1ee7ng c\u1ed1<br\/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 315,50 USD - T\u0103ng \u0111\u00e0 h\u01b0\u1edbng t\u1edbi c\u00e1c ch\u1ea5t x\u00fac t\u00e1c m\u00f9a h\u00e8<br\/> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 305,00 USD - Th\u1ea5t v\u1ecdng l\u1ee3i nhu\u1eadn Q2<br\/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 305,35 USD - \u1ed4n \u0111\u1ecbnh hi\u1ec7n t\u1ea1i<\/p> <p>\u0110i\u1ec1u n\u00e0y \u0111\u1ea1i di\u1ec7n cho kho\u1ea3ng <strong>t\u0103ng tr\u01b0\u1edfng 5%<\/strong> trong s\u00e1u th\u00e1ng, v\u01b0\u1ee3t tr\u1ed9i \u0111\u00e1ng k\u1ec3 so v\u1edbi nhi\u1ec1u \u0111\u1ed1i th\u1ee7 trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc trong giai \u0111o\u1ea1n kh\u00f3 kh\u0103n c\u1ee7a ng\u00e0nh. C\u1ed5 phi\u1ebfu \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 ki\u00ean c\u01b0\u1eddng m\u1eb7c d\u00f9 b\u1ecf l\u1ee1 \u01b0\u1edbc t\u00ednh EPS Q2, cho th\u1ea5y s\u1ee9c m\u1ea1nh n\u1ec1n t\u1ea3ng trong kinh doanh c\u1ed1t l\u00f5i c\u1ee7a h\u1ecd.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 n\u1ec1n t\u1ea3ng c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 340-360 USD (ti\u1ec1m n\u0103ng t\u0103ng 20%) \u2192 <strong>MUA<\/strong><br\/> Ch\u1ea5t x\u00fac t\u00e1c TETON 2 th\u00e1ng 9 c\u00f3 th\u1ec3 th\u00fac \u0111\u1ea9y l\u1ee3i nhu\u1eadn ngay l\u1eadp t\u1ee9c, trong khi l\u1ee3i nhu\u1eadn Q3 v\u00e0 Q4 s\u1ebd x\u00e2y d\u1ef1ng \u0111\u00e0 t\u0103ng.<\/p> <p><strong>D\u1ef1 b\u00e1o 2026<\/strong>: 380-420 USD<br\/> Th\u00e0nh c\u00f4ng trong vi\u1ec7c th\u00e2m nh\u1eadp th\u1ecb tr\u01b0\u1eddng IPF v\u00e0 t\u0103ng tr\u01b0\u1edfng h\u1eefu c\u01a1 ti\u1ebfp t\u1ee5c t\u1eeb d\u00f2ng s\u1ea3n ph\u1ea9m ph\u1ed5i hi\u1ec7n c\u00f3.<\/p> <p><strong>D\u1ef1 \u0111o\u00e1n 2028<\/strong>: 500-600 USD<br\/> C\u00f4ng ngh\u1ec7 s\u1ea3n xu\u1ea5t c\u01a1 quan b\u1eaft \u0111\u1ea7u \u0111\u00f3ng g\u00f3p \u0111\u00e1ng k\u1ec3 v\u00e0o doanh thu.<\/p> <p><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 700-800+ USD<br\/> Xenotransplantation v\u00e0 c\u01a1 quan in sinh h\u1ecdc c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a y h\u1ecdc c\u1ea5y gh\u00e9p.<\/p> <p>C\u00e1c nh\u00e0 ph\u00e2n t\u00edch t\u1eeb <a href=\"https:\/\/stockanalysis.com\/stocks\/uthr\/forecast\/\">StockAnalysis<\/a> duy tr\u00ec \u0111\u00e1nh gi\u00e1 \u0111\u1ed3ng thu\u1eadn \"Mua\" v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh kho\u1ea3ng 382 USD, th\u1ec3 hi\u1ec7n ti\u1ec1m n\u0103ng t\u0103ng \u0111\u00e1ng k\u1ec3 so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro \u0110\u1ea7u T\u01b0: Nh\u1eefng \u0110i\u1ec1u C\u00f3 Th\u1ec3 Sai<\/h2> <h3>R\u1ee7i Ro Ph\u00e1p L\u00fd v\u00e0 L\u00e2m S\u00e0ng<\/h3> <p>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m TETON 2 s\u1ebd l\u00e0 th\u1ea3m h\u1ecda\u2014c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m ngay 30-40%. Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed1i m\u1eb7t v\u1edbi s\u1ef1 gi\u00e1m s\u00e1t ph\u00e1p l\u00fd nghi\u00eam ng\u1eb7t, v\u00e0 b\u1ea5t k\u1ef3 s\u1ef1 ch\u1eadm tr\u1ec5 ho\u1eb7c t\u1eeb ch\u1ed1i n\u00e0o t\u1eeb FDA c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng l\u1edbn \u0111\u1ebfn ti\u1ebfn \u0111\u1ed9 v\u00e0 d\u1ef1 b\u00e1o doanh thu.<\/p> <h3>\u00c1p L\u1ef1c C\u1ea1nh Tranh<\/h3> <p>United Therapeutics \u0111ang \u0111\u1ed1i m\u1eb7t v\u1edbi s\u1ef1 c\u1ea1nh tranh ng\u00e0y c\u00e0ng t\u0103ng t\u1eeb c\u00e1c c\u00f4ng ty c\u00f3 ngu\u1ed3n l\u1ef1c t\u00e0i ch\u00ednh l\u1edbn h\u01a1n. S\u1ef1 xu\u1ea5t hi\u1ec7n c\u1ee7a c\u00e1c \u0111\u1ed1i th\u1ee7 c\u1ea1nh tranh thu\u1ed1c g\u1ed1c \u0111e d\u1ecda s\u1ee9c m\u1ea1nh \u0111\u1ecbnh gi\u00e1 c\u1ee7a c\u00e1c s\u1ea3n ph\u1ea9m hi\u1ec7n c\u00f3, \u0111\u1eb7c bi\u1ec7t khi c\u00e1c b\u1eb1ng s\u00e1ng ch\u1ebf h\u1ebft h\u1ea1n.<\/p> <h3>Y\u1ebfu T\u1ed1 T\u00e0i Ch\u00ednh<\/h3> <p>M\u1eb7c d\u00f9 d\u00f2ng ti\u1ec1n ho\u1ea1t \u0111\u1ed9ng m\u1ea1nh, chi ph\u00ed v\u1eadn h\u00e0nh \u0111\u00e3 t\u0103ng m\u1ea1nh t\u1eeb 321,4 tri\u1ec7u USD l\u00ean 411,6 tri\u1ec7u USD theo c\u00e1c b\u00e1o c\u00e1o g\u1ea7n \u0111\u00e2y. S\u1ef1 t\u0103ng chi ph\u00ed n\u00e0y c\u00f3 th\u1ec3 g\u00e2y \u00e1p l\u1ef1c l\u00ean bi\u00ean l\u1ee3i nhu\u1eadn n\u1ebfu kh\u00f4ng \u0111\u01b0\u1ee3c b\u00f9 \u0111\u1eafp b\u1eb1ng t\u0103ng tr\u01b0\u1edfng doanh thu.<\/p> <h2>\ud83d\ude80 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c: T\u1ea1i Sao UTHR C\u00f3 Th\u1ec3 Bay Cao<\/h2> <h3>Ch\u1ea5t X\u00fac T\u00e1c Ngay L\u1eadp T\u1ee9c<\/h3> <p>K\u1ebft qu\u1ea3 TETON 2 th\u00e1ng 9 n\u0103m 2025 \u0111\u1ea1i di\u1ec7n cho m\u1ed9t kho\u1ea3nh kh\u1eafc t\u00e1i \u0111\u1ecbnh ngh\u0129a th\u1ecb tr\u01b0\u1eddng ti\u1ec1m n\u0103ng. D\u1eef li\u1ec7u t\u00edch c\u1ef1c c\u00f3 th\u1ec3 m\u1edf ra th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb IPF tr\u1ecb gi\u00e1 7,15 t\u1ef7 USD m\u00e0 United Therapeutics c\u00f3 v\u1ecb th\u1ebf chi\u1ebfm l\u0129nh \u0111\u00e1ng k\u1ec3.<\/p> <h3>N\u1ec1n T\u1ea3ng T\u00e0i Ch\u00ednh M\u1ea1nh M\u1ebd<\/h3> <p>V\u1edbi d\u00f2ng ti\u1ec1n ho\u1ea1t \u0111\u1ed9ng 1,2 t\u1ef7 USD v\u00e0 ch\u01b0\u01a1ng tr\u00ecnh mua l\u1ea1i c\u1ed5 phi\u1ebfu tr\u1ecb gi\u00e1 1 t\u1ef7 USD, c\u00f4ng ty c\u00f3 ngu\u1ed3n l\u1ef1c \u0111\u00e1ng k\u1ec3 \u0111\u1ec3 v\u01b0\u1ee3t qua bi\u1ebfn \u0111\u1ed9ng v\u00e0 tr\u1ea3 gi\u00e1 tr\u1ecb cho c\u1ed5 \u0111\u00f4ng.<\/p> <h3>\u0110\u01b0\u1eddng \u1ed0ng \u0110\u1ed5i M\u1edbi<\/h3> <p>B\u00ean c\u1ea1nh d\u01b0\u1ee3c ph\u1ea9m truy\u1ec1n th\u1ed1ng, United Therapeutics \u0111ang ti\u00ean phong c\u00f4ng ngh\u1ec7 s\u1ea3n xu\u1ea5t c\u01a1 quan c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u0103n b\u1ea3n y h\u1ecdc c\u1ea5y gh\u00e9p\u2014m\u1ed9t th\u1ecb tr\u01b0\u1eddng ti\u1ec1m n\u0103ng tr\u1ecb gi\u00e1 h\u00e0ng t\u1ef7 \u0111\u00f4 la.<\/p> <h3>Ni\u1ec1m Tin T\u1eeb C\u00e1c T\u1ed5 Ch\u1ee9c<\/h3> <p>Nh\u1eefng nh\u00e0 \u0111\u1ea7u t\u01b0 l\u1edbn nh\u01b0 Vanguard Group \u0111\u00e3 t\u0103ng v\u1ecb th\u1ebf, ph\u1ea3n \u00e1nh s\u1ef1 tin t\u01b0\u1edfng c\u1ee7a c\u00e1c nh\u00e0 qu\u1ea3n l\u00fd ti\u1ec1n chuy\u00ean nghi\u1ec7p v\u00e0o tri\u1ec3n v\u1ecdng d\u00e0i h\u1ea1n c\u1ee7a c\u00f4ng ty.<\/p> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>Ch\u1edd Ch\u1ea5t X\u00fac T\u00e1c Th\u00e1ng 9<\/strong>: K\u1ebft qu\u1ea3 TETON 2 s\u1ebd cung c\u1ea5p s\u1ef1 r\u00f5 r\u00e0ng\u2014h\u00e3y c\u00e2n nh\u1eafc thi\u1ebft l\u1eadp v\u1ecb th\u1ebf sau khi d\u1eef li\u1ec7u \u0111\u01b0\u1ee3c c\u00f4ng b\u1ed1 b\u1ea5t k\u1ec3 k\u1ebft qu\u1ea3 th\u1ebf n\u00e0o<\/li> <li><strong>Trung B\u00ecnh Gi\u00e1 Mua<\/strong>: N\u1ebfu mua tr\u01b0\u1edbc th\u00e1ng 9, h\u00e3y s\u1eed d\u1ee5ng c\u00e1c kho\u1ea3n mua nh\u1ecf d\u1ea7n \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m<\/li> <li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 kho\u1ea3n \u0111\u1ea7u t\u01b0 v\u1edbi l\u1ec7nh c\u1eaft l\u1ed7 15-20% do t\u00ednh ch\u1ea5t nh\u1ecb ph\u00e2n c\u1ee7a d\u1eef li\u1ec7u l\u00e2m s\u00e0ng<\/li> <li><strong>Ph\u00e2n B\u1ed5 H\u1ee3p L\u00fd<\/strong>: Gi\u1edbi h\u1ea1n UTHR kh\u00f4ng qu\u00e1 5-10% t\u1ed5ng danh m\u1ee5c do s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ee7a ng\u00e0nh<\/li> <\/ol> <p>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a c\u00e1c nh\u00e0 giao d\u1ecbch k\u1ef3 c\u1ef1u: \"Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc gi\u1ed1ng nh\u01b0 ph\u1eabu thu\u1eadt\u2014\u0111\u00f4i khi b\u1ea1n c\u1ea7n \u0111\u00f4i tay v\u1eefng v\u00e0ng, \u0111\u00f4i khi b\u1ea1n c\u1ea7n bi\u1ebft khi n\u00e0o n\u00ean r\u1eddi b\u00e0n m\u1ed5 tr\u01b0\u1edbc khi m\u1ecdi th\u1ee9 tr\u1edf n\u00ean l\u1ed9n x\u1ed9n!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu United Therapeutics Corporation (UTHR) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p truy c\u1eadp NASDAQ v\u00e0 ph\u00ed hoa h\u1ed3ng h\u1ee3p l\u00fd<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n Th\u00e0nh X\u00e1c Minh T\u00e0i Kho\u1ea3n<\/td><td>Cung c\u1ea5p gi\u1ea5y t\u1edd t\u00f9y th\u00e2n\u2014th\u01b0\u1eddng m\u1ea5t 1-2 ng\u00e0y l\u00e0m vi\u1ec7c<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td><td>Chuy\u1ec3n ti\u1ec1n qua chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng, chuy\u1ec3n ti\u1ec1n \u0111i\u1ec7n t\u1eed ho\u1eb7c c\u00e1c ph\u01b0\u01a1ng th\u1ee9c c\u00f3 s\u1eb5n kh\u00e1c<\/td><\/tr> <tr><td>4<\/td><td>Nghi\u00ean C\u1ee9u K\u1ef9 V\u1ec1 UTHR<\/td><td>Hi\u1ec3u r\u00f5 s\u1ea3n ph\u1ea9m, \u0111\u01b0\u1eddng \u1ed1ng ph\u00e1t tri\u1ec3n v\u00e0 r\u1ee7i ro tr\u01b0\u1edbc khi \u0111\u1ea7u t\u01b0<\/td><\/tr> <tr><td>5<\/td><td>\u0110\u1eb7t L\u1ec7nh Mua<\/td><td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td><\/tr> <tr><td>6<\/td><td>Gi\u00e1m S\u00e1t Kho\u1ea3n \u0110\u1ea7u T\u01b0<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 v\u00e0 th\u01b0\u1eddng xuy\u00ean theo d\u00f5i tin t\u1ee9c, di\u1ec5n bi\u1ebfn c\u00f4ng ty<\/td><\/tr> <tr><td>7<\/td><td>Xem X\u00e9t T\u00e1c \u0110\u1ed9ng Thu\u1ebf<\/td><td>Hi\u1ec3u y\u00eau c\u1ea7u v\u1ec1 th\u1eddi gian n\u1eafm gi\u1eef \u0111\u1ec3 \u0111\u01b0\u1ee3c \u01b0u \u0111\u00e3i thu\u1ebf<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option N\u1ed5i B\u1eadt Cho Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf gi\u00fap ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu nh\u01b0 UTHR d\u1ec5 d\u00e0ng h\u01a1n:<\/p> <ul> <li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u Ch\u1ec9 5 USD<\/strong> - B\u1eaft \u0111\u1ea7u v\u1edbi b\u1ea5t k\u1ef3 s\u1ed1 ti\u1ec1n n\u00e0o, l\u00fd t\u01b0\u1edfng \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li> <li><strong>Quy Tr\u00ecnh X\u00e1c Minh Nhanh<\/strong> - Ho\u00e0n th\u00e0nh KYC ch\u1ec9 v\u1edbi m\u1ed9t gi\u1ea5y t\u1edd, th\u01b0\u1eddng \u0111\u01b0\u1ee3c duy\u1ec7t trong v\u00e0i ph\u00fat thay v\u00ec v\u00e0i ng\u00e0y<\/li> <li><strong>Nhi\u1ec1u Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong> - H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 c\u00e1c l\u1ef1a ch\u1ecdn ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng<\/li> <li><strong>N\u1ec1n T\u1ea3ng Th\u00e2n Thi\u1ec7n Ng\u01b0\u1eddi D\u00f9ng<\/strong> - Giao di\u1ec7n tr\u1ef1c quan thi\u1ebft k\u1ebf ri\u00eang cho ng\u01b0\u1eddi m\u1edbi \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu<\/li> <\/ul> <h2>\ud83c\udf0d United Therapeutics N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Y H\u1ecdc<\/h2> <p>United Therapeutics Corporation \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1edbi tr\u1ecdng t\u00e2m k\u00e9p: ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u1ee9u s\u1ed1ng cho b\u1ec7nh ph\u1ed5i v\u00e0 ti\u00ean phong t\u01b0\u01a1ng lai c\u1ee7a c\u1ea5y gh\u00e9p c\u01a1 quan. V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i c\u1ee7a c\u00f4ng ty r\u1ea5t m\u1ea1nh, v\u1edbi danh m\u1ee5c \u0111a d\u1ea1ng bao g\u1ed3m Tyvaso DPI, Remodulin, Orenitram v\u00e0 Unituxin\u2014c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u1ea3i thi\u1ec7n \u0111\u00e1ng k\u1ec3 cu\u1ed9c s\u1ed1ng b\u1ec7nh nh\u00e2n.<\/p> <p>C\u00f4ng ty ho\u1ea1t \u0111\u1ed9ng nh\u01b0 m\u1ed9t c\u00f4ng ty v\u00ec l\u1ee3i \u00edch c\u1ed9ng \u0111\u1ed3ng, c\u1ee7ng c\u1ed1 cam k\u1ebft tr\u00e1ch nhi\u1ec7m x\u00e3 h\u1ed9i b\u00ean c\u1ea1nh gi\u00e1 tr\u1ecb c\u1ed5 \u0111\u00f4ng. V\u1edbi kho\u1ea3ng 1.305 nh\u00e2n vi\u00ean v\u00e0 c\u00e1c c\u01a1 s\u1edf t\u1ea1i Maryland, North Carolina, Quebec, Florida, Virginia v\u00e0 New Hampshire, United Therapeutics \u0111\u00e3 x\u00e2y d\u1ef1ng n\u1ec1n t\u1ea3ng v\u1eadn h\u00e0nh v\u1eefng ch\u1eafc cho t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng.<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: United Therapeutics hi\u1ec7n \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c c\u01a1 quan \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t th\u00f4ng qua ba c\u00f4ng ngh\u1ec7 c\u00e1ch m\u1ea1ng\u2014xenotransplantation (s\u1eed d\u1ee5ng c\u01a1 quan \u0111\u1ed9ng v\u1eadt), t\u00e1i t\u1ebf b\u00e0o h\u00f3a \u0111\u1ed3ng lo\u1ea1i v\u00e0 in sinh h\u1ecdc t\u1ef1 th\u00e2n. H\u1ecd v\u1ec1 c\u01a1 b\u1ea3n \u0111ang t\u1ea1o ra \"nh\u00e0 thu\u1ed1c c\u01a1 quan\" \u0111\u1ea7u ti\u00ean tr\u00ean th\u1ebf gi\u1edbi, n\u01a1i b\u1ec7nh nh\u00e2n c\u00f3 th\u1ec3 \u0111\u1eb7t h\u00e0ng c\u01a1 quan thay th\u1ebf khi c\u1ea7n!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu United Therapeutics: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 28 th\u00e1ng 8 n\u0103m 2025, United Therapeutics Corporation (UTHR) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>305,35 USD<\/strong>\u2014m\u1ed9t m\u1ee9c quan tr\u1ecdng \u0111\u1ea1i di\u1ec7n cho c\u1ea3 c\u01a1 h\u1ed9i v\u00e0 s\u1ef1 th\u1eadn tr\u1ecdng \u0111\u1ed1i v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0. Nh\u01b0ng h\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: <strong>Th\u00e1ng 9 n\u0103m 2025 c\u00f3 th\u1ec3 thay \u0111\u1ed5i m\u1ecdi th\u1ee9<\/strong> \u0111\u1ed1i v\u1edbi c\u1ed5 phi\u1ebfu n\u00e0y.<\/p>\n<p>K\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng TETON 2 s\u1eafp t\u1edbi v\u1ec1 treprostinil d\u1ea1ng kh\u00ed dung trong b\u1ec7nh x\u01a1 ph\u1ed5i v\u00f4 c\u0103n (IPF) c\u00f3 th\u1ec3 l\u00e0 b\u01b0\u1edbc ngo\u1eb7t l\u1edbn. C\u00e1c nh\u00e0 ph\u00e2n t\u00edch t\u1eeb <a href=\"https:\/\/finimize.com\/content\/united-therapeutics-puts-big-bets-on-tyvasos-trial-results\">Finimize<\/a> cho r\u1eb1ng k\u1ebft qu\u1ea3 t\u00edch c\u1ef1c c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu t\u0103ng m\u1ea1nh, trong khi <a href=\"https:\/\/www.ainvest.com\/news\/united-therapeutics-september-ipf-data-readout-strategic-catalyst-shareholder-2508\/\">AI Invest<\/a> g\u1ecdi \u0111\u00e2y l\u00e0 &#8220;ch\u1ea5t x\u00fac t\u00e1c chi\u1ebfn l\u01b0\u1ee3c cho gi\u00e1 tr\u1ecb c\u1ed5 \u0111\u00f4ng.&#8221;<\/p>\n<h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng L\u1ee3i Nhu\u1eadn L\u1ecbch S\u1eed<\/h3>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<th>Ph\u00e2n T\u00edch<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>30 th\u00e1ng 7, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn Q2<\/td>\n<td>312,00 USD<\/td>\n<td>-2,1% (b\u1ecf l\u1ee1 \u01b0\u1edbc t\u00ednh EPS)<\/td>\n<td>T\u0103ng tr\u01b0\u1edfng doanh thu nh\u01b0ng EPS g\u00e2y th\u1ea5t v\u1ecdng<\/td>\n<\/tr>\n<tr>\n<td>30 th\u00e1ng 4, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn Q1<\/td>\n<td>298,50 USD<\/td>\n<td>+4,5% (v\u01b0\u1ee3t \u01b0\u1edbc t\u00ednh)<\/td>\n<td>Hi\u1ec7u su\u1ea5t s\u1ea3n ph\u1ea9m m\u1ea1nh m\u1ebd<\/td>\n<\/tr>\n<tr>\n<td>26 th\u00e1ng 2, 2025<\/td>\n<td>L\u1ee3i nhu\u1eadn Q4 2024<\/td>\n<td>290,75 USD<\/td>\n<td>+3,2% (k\u1ebft qu\u1ea3 v\u1eefng ch\u1eafc)<\/td>\n<td>M\u00f4 h\u00ecnh t\u0103ng tr\u01b0\u1edfng \u1ed5n \u0111\u1ecbnh<\/td>\n<\/tr>\n<tr>\n<td>29 th\u00e1ng 10, 2024<\/td>\n<td>L\u1ee3i nhu\u1eadn Q3 2024<\/td>\n<td>285,25 USD<\/td>\n<td>+1,9% (\u0111\u1ea1t k\u1ef3 v\u1ecdng)<\/td>\n<td>Hi\u1ec7u su\u1ea5t \u1ed5n \u0111\u1ecbnh<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>M\u00f4 h\u00ecnh cho th\u1ea5y UTHR th\u01b0\u1eddng tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng 2-5% quanh c\u00e1c k\u1ef3 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn, nh\u01b0ng k\u1ebft qu\u1ea3 TETON 2 th\u00e1ng 9 c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t bi\u1ebfn \u0111\u1ed9ng l\u1edbn h\u01a1n t\u1eeb 15-25% d\u1ef1a tr\u00ean c\u00e1c s\u1ef1 ki\u1ec7n ch\u1ea5t x\u00fac t\u00e1c sinh h\u1ecdc l\u1ecbch s\u1eed.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng v\u00e0 Ph\u00e2n T\u00edch Xu H\u01b0\u1edbng<\/h2>\n<p>United Therapeutics \u0111\u00e3 tr\u1ea3i qua m\u1ed9t qu\u1ef9 \u0111\u1ea1o bi\u1ebfn \u0111\u1ed9ng nh\u01b0ng cu\u1ed1i c\u00f9ng l\u00e0 t\u00edch c\u1ef1c trong s\u00e1u th\u00e1ng qua:<\/p>\n<p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: 290,75 USD &#8211; K\u1ebft qu\u1ea3 Q4 m\u1ea1nh m\u1ebd t\u1ea1o n\u1ec1n t\u1ea3ng<br \/> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 302,40 USD &#8211; Th\u1ecb tr\u01b0\u1eddng k\u1ef3 v\u1ecdng l\u1ee3i nhu\u1eadn Q1<br \/> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: 312,00 USD &#8211; T\u0103ng sau b\u00e1o c\u00e1o v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<br \/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 308,25 USD &#8211; Ch\u1ed1t l\u1eddi v\u00e0 c\u1ee7ng c\u1ed1<br \/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: 315,50 USD &#8211; T\u0103ng \u0111\u00e0 h\u01b0\u1edbng t\u1edbi c\u00e1c ch\u1ea5t x\u00fac t\u00e1c m\u00f9a h\u00e8<br \/> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 305,00 USD &#8211; Th\u1ea5t v\u1ecdng l\u1ee3i nhu\u1eadn Q2<br \/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 305,35 USD &#8211; \u1ed4n \u0111\u1ecbnh hi\u1ec7n t\u1ea1i<\/p>\n<p>\u0110i\u1ec1u n\u00e0y \u0111\u1ea1i di\u1ec7n cho kho\u1ea3ng <strong>t\u0103ng tr\u01b0\u1edfng 5%<\/strong> trong s\u00e1u th\u00e1ng, v\u01b0\u1ee3t tr\u1ed9i \u0111\u00e1ng k\u1ec3 so v\u1edbi nhi\u1ec1u \u0111\u1ed1i th\u1ee7 trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc trong giai \u0111o\u1ea1n kh\u00f3 kh\u0103n c\u1ee7a ng\u00e0nh. C\u1ed5 phi\u1ebfu \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 ki\u00ean c\u01b0\u1eddng m\u1eb7c d\u00f9 b\u1ecf l\u1ee1 \u01b0\u1edbc t\u00ednh EPS Q2, cho th\u1ea5y s\u1ee9c m\u1ea1nh n\u1ec1n t\u1ea3ng trong kinh doanh c\u1ed1t l\u00f5i c\u1ee7a h\u1ecd.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 n\u1ec1n t\u1ea3ng c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 340-360 USD (ti\u1ec1m n\u0103ng t\u0103ng 20%) \u2192 <strong>MUA<\/strong><br \/> Ch\u1ea5t x\u00fac t\u00e1c TETON 2 th\u00e1ng 9 c\u00f3 th\u1ec3 th\u00fac \u0111\u1ea9y l\u1ee3i nhu\u1eadn ngay l\u1eadp t\u1ee9c, trong khi l\u1ee3i nhu\u1eadn Q3 v\u00e0 Q4 s\u1ebd x\u00e2y d\u1ef1ng \u0111\u00e0 t\u0103ng.<\/p>\n<p><strong>D\u1ef1 b\u00e1o 2026<\/strong>: 380-420 USD<br \/> Th\u00e0nh c\u00f4ng trong vi\u1ec7c th\u00e2m nh\u1eadp th\u1ecb tr\u01b0\u1eddng IPF v\u00e0 t\u0103ng tr\u01b0\u1edfng h\u1eefu c\u01a1 ti\u1ebfp t\u1ee5c t\u1eeb d\u00f2ng s\u1ea3n ph\u1ea9m ph\u1ed5i hi\u1ec7n c\u00f3.<\/p>\n<p><strong>D\u1ef1 \u0111o\u00e1n 2028<\/strong>: 500-600 USD<br \/> C\u00f4ng ngh\u1ec7 s\u1ea3n xu\u1ea5t c\u01a1 quan b\u1eaft \u0111\u1ea7u \u0111\u00f3ng g\u00f3p \u0111\u00e1ng k\u1ec3 v\u00e0o doanh thu.<\/p>\n<p><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 700-800+ USD<br \/> Xenotransplantation v\u00e0 c\u01a1 quan in sinh h\u1ecdc c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a y h\u1ecdc c\u1ea5y gh\u00e9p.<\/p>\n<p>C\u00e1c nh\u00e0 ph\u00e2n t\u00edch t\u1eeb <a href=\"https:\/\/stockanalysis.com\/stocks\/uthr\/forecast\/\">StockAnalysis<\/a> duy tr\u00ec \u0111\u00e1nh gi\u00e1 \u0111\u1ed3ng thu\u1eadn &#8220;Mua&#8221; v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh kho\u1ea3ng 382 USD, th\u1ec3 hi\u1ec7n ti\u1ec1m n\u0103ng t\u0103ng \u0111\u00e1ng k\u1ec3 so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro \u0110\u1ea7u T\u01b0: Nh\u1eefng \u0110i\u1ec1u C\u00f3 Th\u1ec3 Sai<\/h2>\n<h3>R\u1ee7i Ro Ph\u00e1p L\u00fd v\u00e0 L\u00e2m S\u00e0ng<\/h3>\n<p>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m TETON 2 s\u1ebd l\u00e0 th\u1ea3m h\u1ecda\u2014c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m ngay 30-40%. Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed1i m\u1eb7t v\u1edbi s\u1ef1 gi\u00e1m s\u00e1t ph\u00e1p l\u00fd nghi\u00eam ng\u1eb7t, v\u00e0 b\u1ea5t k\u1ef3 s\u1ef1 ch\u1eadm tr\u1ec5 ho\u1eb7c t\u1eeb ch\u1ed1i n\u00e0o t\u1eeb FDA c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng l\u1edbn \u0111\u1ebfn ti\u1ebfn \u0111\u1ed9 v\u00e0 d\u1ef1 b\u00e1o doanh thu.<\/p>\n<h3>\u00c1p L\u1ef1c C\u1ea1nh Tranh<\/h3>\n<p>United Therapeutics \u0111ang \u0111\u1ed1i m\u1eb7t v\u1edbi s\u1ef1 c\u1ea1nh tranh ng\u00e0y c\u00e0ng t\u0103ng t\u1eeb c\u00e1c c\u00f4ng ty c\u00f3 ngu\u1ed3n l\u1ef1c t\u00e0i ch\u00ednh l\u1edbn h\u01a1n. S\u1ef1 xu\u1ea5t hi\u1ec7n c\u1ee7a c\u00e1c \u0111\u1ed1i th\u1ee7 c\u1ea1nh tranh thu\u1ed1c g\u1ed1c \u0111e d\u1ecda s\u1ee9c m\u1ea1nh \u0111\u1ecbnh gi\u00e1 c\u1ee7a c\u00e1c s\u1ea3n ph\u1ea9m hi\u1ec7n c\u00f3, \u0111\u1eb7c bi\u1ec7t khi c\u00e1c b\u1eb1ng s\u00e1ng ch\u1ebf h\u1ebft h\u1ea1n.<\/p>\n<h3>Y\u1ebfu T\u1ed1 T\u00e0i Ch\u00ednh<\/h3>\n<p>M\u1eb7c d\u00f9 d\u00f2ng ti\u1ec1n ho\u1ea1t \u0111\u1ed9ng m\u1ea1nh, chi ph\u00ed v\u1eadn h\u00e0nh \u0111\u00e3 t\u0103ng m\u1ea1nh t\u1eeb 321,4 tri\u1ec7u USD l\u00ean 411,6 tri\u1ec7u USD theo c\u00e1c b\u00e1o c\u00e1o g\u1ea7n \u0111\u00e2y. S\u1ef1 t\u0103ng chi ph\u00ed n\u00e0y c\u00f3 th\u1ec3 g\u00e2y \u00e1p l\u1ef1c l\u00ean bi\u00ean l\u1ee3i nhu\u1eadn n\u1ebfu kh\u00f4ng \u0111\u01b0\u1ee3c b\u00f9 \u0111\u1eafp b\u1eb1ng t\u0103ng tr\u01b0\u1edfng doanh thu.<\/p>\n<h2>\ud83d\ude80 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c: T\u1ea1i Sao UTHR C\u00f3 Th\u1ec3 Bay Cao<\/h2>\n<h3>Ch\u1ea5t X\u00fac T\u00e1c Ngay L\u1eadp T\u1ee9c<\/h3>\n<p>K\u1ebft qu\u1ea3 TETON 2 th\u00e1ng 9 n\u0103m 2025 \u0111\u1ea1i di\u1ec7n cho m\u1ed9t kho\u1ea3nh kh\u1eafc t\u00e1i \u0111\u1ecbnh ngh\u0129a th\u1ecb tr\u01b0\u1eddng ti\u1ec1m n\u0103ng. D\u1eef li\u1ec7u t\u00edch c\u1ef1c c\u00f3 th\u1ec3 m\u1edf ra th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb IPF tr\u1ecb gi\u00e1 7,15 t\u1ef7 USD m\u00e0 United Therapeutics c\u00f3 v\u1ecb th\u1ebf chi\u1ebfm l\u0129nh \u0111\u00e1ng k\u1ec3.<\/p>\n<h3>N\u1ec1n T\u1ea3ng T\u00e0i Ch\u00ednh M\u1ea1nh M\u1ebd<\/h3>\n<p>V\u1edbi d\u00f2ng ti\u1ec1n ho\u1ea1t \u0111\u1ed9ng 1,2 t\u1ef7 USD v\u00e0 ch\u01b0\u01a1ng tr\u00ecnh mua l\u1ea1i c\u1ed5 phi\u1ebfu tr\u1ecb gi\u00e1 1 t\u1ef7 USD, c\u00f4ng ty c\u00f3 ngu\u1ed3n l\u1ef1c \u0111\u00e1ng k\u1ec3 \u0111\u1ec3 v\u01b0\u1ee3t qua bi\u1ebfn \u0111\u1ed9ng v\u00e0 tr\u1ea3 gi\u00e1 tr\u1ecb cho c\u1ed5 \u0111\u00f4ng.<\/p>\n<h3>\u0110\u01b0\u1eddng \u1ed0ng \u0110\u1ed5i M\u1edbi<\/h3>\n<p>B\u00ean c\u1ea1nh d\u01b0\u1ee3c ph\u1ea9m truy\u1ec1n th\u1ed1ng, United Therapeutics \u0111ang ti\u00ean phong c\u00f4ng ngh\u1ec7 s\u1ea3n xu\u1ea5t c\u01a1 quan c\u00f3 th\u1ec3 thay \u0111\u1ed5i c\u0103n b\u1ea3n y h\u1ecdc c\u1ea5y gh\u00e9p\u2014m\u1ed9t th\u1ecb tr\u01b0\u1eddng ti\u1ec1m n\u0103ng tr\u1ecb gi\u00e1 h\u00e0ng t\u1ef7 \u0111\u00f4 la.<\/p>\n<h3>Ni\u1ec1m Tin T\u1eeb C\u00e1c T\u1ed5 Ch\u1ee9c<\/h3>\n<p>Nh\u1eefng nh\u00e0 \u0111\u1ea7u t\u01b0 l\u1edbn nh\u01b0 Vanguard Group \u0111\u00e3 t\u0103ng v\u1ecb th\u1ebf, ph\u1ea3n \u00e1nh s\u1ef1 tin t\u01b0\u1edfng c\u1ee7a c\u00e1c nh\u00e0 qu\u1ea3n l\u00fd ti\u1ec1n chuy\u00ean nghi\u1ec7p v\u00e0o tri\u1ec3n v\u1ecdng d\u00e0i h\u1ea1n c\u1ee7a c\u00f4ng ty.<\/p>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>Ch\u1edd Ch\u1ea5t X\u00fac T\u00e1c Th\u00e1ng 9<\/strong>: K\u1ebft qu\u1ea3 TETON 2 s\u1ebd cung c\u1ea5p s\u1ef1 r\u00f5 r\u00e0ng\u2014h\u00e3y c\u00e2n nh\u1eafc thi\u1ebft l\u1eadp v\u1ecb th\u1ebf sau khi d\u1eef li\u1ec7u \u0111\u01b0\u1ee3c c\u00f4ng b\u1ed1 b\u1ea5t k\u1ec3 k\u1ebft qu\u1ea3 th\u1ebf n\u00e0o<\/li>\n<li><strong>Trung B\u00ecnh Gi\u00e1 Mua<\/strong>: N\u1ebfu mua tr\u01b0\u1edbc th\u00e1ng 9, h\u00e3y s\u1eed d\u1ee5ng c\u00e1c kho\u1ea3n mua nh\u1ecf d\u1ea7n \u0111\u1ec3 gi\u1ea3m r\u1ee7i ro th\u1eddi \u0111i\u1ec3m<\/li>\n<li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 kho\u1ea3n \u0111\u1ea7u t\u01b0 v\u1edbi l\u1ec7nh c\u1eaft l\u1ed7 15-20% do t\u00ednh ch\u1ea5t nh\u1ecb ph\u00e2n c\u1ee7a d\u1eef li\u1ec7u l\u00e2m s\u00e0ng<\/li>\n<li><strong>Ph\u00e2n B\u1ed5 H\u1ee3p L\u00fd<\/strong>: Gi\u1edbi h\u1ea1n UTHR kh\u00f4ng qu\u00e1 5-10% t\u1ed5ng danh m\u1ee5c do s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ee7a ng\u00e0nh<\/li>\n<\/ol>\n<p>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a c\u00e1c nh\u00e0 giao d\u1ecbch k\u1ef3 c\u1ef1u: &#8220;Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc gi\u1ed1ng nh\u01b0 ph\u1eabu thu\u1eadt\u2014\u0111\u00f4i khi b\u1ea1n c\u1ea7n \u0111\u00f4i tay v\u1eefng v\u00e0ng, \u0111\u00f4i khi b\u1ea1n c\u1ea7n bi\u1ebft khi n\u00e0o n\u00ean r\u1eddi b\u00e0n m\u1ed5 tr\u01b0\u1edbc khi m\u1ecdi th\u1ee9 tr\u1edf n\u00ean l\u1ed9n x\u1ed9n!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu United Therapeutics Corporation (UTHR) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng cung c\u1ea5p truy c\u1eadp NASDAQ v\u00e0 ph\u00ed hoa h\u1ed3ng h\u1ee3p l\u00fd<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n Th\u00e0nh X\u00e1c Minh T\u00e0i Kho\u1ea3n<\/td>\n<td>Cung c\u1ea5p gi\u1ea5y t\u1edd t\u00f9y th\u00e2n\u2014th\u01b0\u1eddng m\u1ea5t 1-2 ng\u00e0y l\u00e0m vi\u1ec7c<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td>\n<td>Chuy\u1ec3n ti\u1ec1n qua chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng, chuy\u1ec3n ti\u1ec1n \u0111i\u1ec7n t\u1eed ho\u1eb7c c\u00e1c ph\u01b0\u01a1ng th\u1ee9c c\u00f3 s\u1eb5n kh\u00e1c<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Nghi\u00ean C\u1ee9u K\u1ef9 V\u1ec1 UTHR<\/td>\n<td>Hi\u1ec3u r\u00f5 s\u1ea3n ph\u1ea9m, \u0111\u01b0\u1eddng \u1ed1ng ph\u00e1t tri\u1ec3n v\u00e0 r\u1ee7i ro tr\u01b0\u1edbc khi \u0111\u1ea7u t\u01b0<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0110\u1eb7t L\u1ec7nh Mua<\/td>\n<td>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Gi\u00e1m S\u00e1t Kho\u1ea3n \u0110\u1ea7u T\u01b0<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 v\u00e0 th\u01b0\u1eddng xuy\u00ean theo d\u00f5i tin t\u1ee9c, di\u1ec5n bi\u1ebfn c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Xem X\u00e9t T\u00e1c \u0110\u1ed9ng Thu\u1ebf<\/td>\n<td>Hi\u1ec3u y\u00eau c\u1ea7u v\u1ec1 th\u1eddi gian n\u1eafm gi\u1eef \u0111\u1ec3 \u0111\u01b0\u1ee3c \u01b0u \u0111\u00e3i thu\u1ebf<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option N\u1ed5i B\u1eadt Cho Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf gi\u00fap ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu nh\u01b0 UTHR d\u1ec5 d\u00e0ng h\u01a1n:<\/p>\n<ul>\n<li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u Ch\u1ec9 5 USD<\/strong> &#8211; B\u1eaft \u0111\u1ea7u v\u1edbi b\u1ea5t k\u1ef3 s\u1ed1 ti\u1ec1n n\u00e0o, l\u00fd t\u01b0\u1edfng \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li>\n<li><strong>Quy Tr\u00ecnh X\u00e1c Minh Nhanh<\/strong> &#8211; Ho\u00e0n th\u00e0nh KYC ch\u1ec9 v\u1edbi m\u1ed9t gi\u1ea5y t\u1edd, th\u01b0\u1eddng \u0111\u01b0\u1ee3c duy\u1ec7t trong v\u00e0i ph\u00fat thay v\u00ec v\u00e0i ng\u00e0y<\/li>\n<li><strong>Nhi\u1ec1u Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong> &#8211; H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 c\u00e1c l\u1ef1a ch\u1ecdn ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng<\/li>\n<li><strong>N\u1ec1n T\u1ea3ng Th\u00e2n Thi\u1ec7n Ng\u01b0\u1eddi D\u00f9ng<\/strong> &#8211; Giao di\u1ec7n tr\u1ef1c quan thi\u1ebft k\u1ebf ri\u00eang cho ng\u01b0\u1eddi m\u1edbi \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu<\/li>\n<\/ul>\n<h2>\ud83c\udf0d United Therapeutics N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Y H\u1ecdc<\/h2>\n<p>United Therapeutics Corporation \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1edbi tr\u1ecdng t\u00e2m k\u00e9p: ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u1ee9u s\u1ed1ng cho b\u1ec7nh ph\u1ed5i v\u00e0 ti\u00ean phong t\u01b0\u01a1ng lai c\u1ee7a c\u1ea5y gh\u00e9p c\u01a1 quan. V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i c\u1ee7a c\u00f4ng ty r\u1ea5t m\u1ea1nh, v\u1edbi danh m\u1ee5c \u0111a d\u1ea1ng bao g\u1ed3m Tyvaso DPI, Remodulin, Orenitram v\u00e0 Unituxin\u2014c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u1ea3i thi\u1ec7n \u0111\u00e1ng k\u1ec3 cu\u1ed9c s\u1ed1ng b\u1ec7nh nh\u00e2n.<\/p>\n<p>C\u00f4ng ty ho\u1ea1t \u0111\u1ed9ng nh\u01b0 m\u1ed9t c\u00f4ng ty v\u00ec l\u1ee3i \u00edch c\u1ed9ng \u0111\u1ed3ng, c\u1ee7ng c\u1ed1 cam k\u1ebft tr\u00e1ch nhi\u1ec7m x\u00e3 h\u1ed9i b\u00ean c\u1ea1nh gi\u00e1 tr\u1ecb c\u1ed5 \u0111\u00f4ng. V\u1edbi kho\u1ea3ng 1.305 nh\u00e2n vi\u00ean v\u00e0 c\u00e1c c\u01a1 s\u1edf t\u1ea1i Maryland, North Carolina, Quebec, Florida, Virginia v\u00e0 New Hampshire, United Therapeutics \u0111\u00e3 x\u00e2y d\u1ef1ng n\u1ec1n t\u1ea3ng v\u1eadn h\u00e0nh v\u1eefng ch\u1eafc cho t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: United Therapeutics hi\u1ec7n \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c c\u01a1 quan \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t th\u00f4ng qua ba c\u00f4ng ngh\u1ec7 c\u00e1ch m\u1ea1ng\u2014xenotransplantation (s\u1eed d\u1ee5ng c\u01a1 quan \u0111\u1ed9ng v\u1eadt), t\u00e1i t\u1ebf b\u00e0o h\u00f3a \u0111\u1ed3ng lo\u1ea1i v\u00e0 in sinh h\u1ecdc t\u1ef1 th\u00e2n. H\u1ecd v\u1ec1 c\u01a1 b\u1ea3n \u0111ang t\u1ea1o ra &#8220;nh\u00e0 thu\u1ed1c c\u01a1 quan&#8221; \u0111\u1ea7u ti\u00ean tr\u00ean th\u1ebf gi\u1edbi, n\u01a1i b\u1ec7nh nh\u00e2n c\u00f3 th\u1ec3 \u0111\u1eb7t h\u00e0ng c\u01a1 quan thay th\u1ebf khi c\u1ea7n!<\/p>\n"},"faq":[{"question":"United Therapeutics Corporation l\u00e0 c\u00f4ng ty g\u00ec?","answer":"United Therapeutics Corporation l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean phong trong ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ph\u1ed5i v\u00e0 c\u00f4ng ngh\u1ec7 s\u1ea3n xu\u1ea5t c\u01a1 quan."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu UTHR?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu UTHR th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, ho\u00e0n th\u00e0nh x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, nghi\u00ean c\u1ee9u k\u1ef9 v\u00e0 \u0111\u1eb7t l\u1ec7nh mua v\u1edbi l\u1ec7nh gi\u1edbi h\u1ea1n."},{"question":"R\u1ee7i ro \u0111\u1ea7u t\u01b0 v\u00e0o UTHR l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, \u00e1p l\u1ef1c c\u1ea1nh tranh, v\u00e0 chi ph\u00ed v\u1eadn h\u00e0nh t\u0103ng c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn l\u1ee3i nhu\u1eadn v\u00e0 gi\u00e1 c\u1ed5 phi\u1ebfu."},{"question":"T\u1ea1i sao th\u00e1ng 9 n\u0103m 2025 quan tr\u1ecdng v\u1edbi UTHR?","answer":"Th\u00e1ng 9 n\u0103m 2025 c\u00f3 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng TETON 2 v\u1ec1 treprostinil d\u1ea1ng kh\u00ed dung trong IPF, c\u00f3 th\u1ec3 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gi\u00e1 c\u1ed5 phi\u1ebfu."},{"question":"Pocket Option c\u00f3 l\u1ee3i th\u1ebf g\u00ec cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 n\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng, ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"United Therapeutics Corporation l\u00e0 c\u00f4ng ty g\u00ec?","answer":"United Therapeutics Corporation l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean phong trong ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ph\u1ed5i v\u00e0 c\u00f4ng ngh\u1ec7 s\u1ea3n xu\u1ea5t c\u01a1 quan."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu UTHR?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu UTHR th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, ho\u00e0n th\u00e0nh x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, nghi\u00ean c\u1ee9u k\u1ef9 v\u00e0 \u0111\u1eb7t l\u1ec7nh mua v\u1edbi l\u1ec7nh gi\u1edbi h\u1ea1n."},{"question":"R\u1ee7i ro \u0111\u1ea7u t\u01b0 v\u00e0o UTHR l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, \u00e1p l\u1ef1c c\u1ea1nh tranh, v\u00e0 chi ph\u00ed v\u1eadn h\u00e0nh t\u0103ng c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn l\u1ee3i nhu\u1eadn v\u00e0 gi\u00e1 c\u1ed5 phi\u1ebfu."},{"question":"T\u1ea1i sao th\u00e1ng 9 n\u0103m 2025 quan tr\u1ecdng v\u1edbi UTHR?","answer":"Th\u00e1ng 9 n\u0103m 2025 c\u00f3 k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng TETON 2 v\u1ec1 treprostinil d\u1ea1ng kh\u00ed dung trong IPF, c\u00f3 th\u1ec3 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gi\u00e1 c\u1ed5 phi\u1ebfu."},{"question":"Pocket Option c\u00f3 l\u1ee3i th\u1ebf g\u00ec cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 n\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng, ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T08:01:18+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)\",\"datePublished\":\"2025-08-28T08:01:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-28T08:01:18+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T08:01:18+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)","datePublished":"2025-08-28T08:01:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-28T08:01:18+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu United Therapeutics Corporation (UTHR)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":353170,"slug":"how-to-buy-united-therapeutics-corporation","post_title":"Como comprar a\u00e7\u00f5es da United Therapeutics Corporation (UTHR) - Investimento em a\u00e7\u00f5es da United Therapeutics Corporation (UTHR)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-united-therapeutics-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/353168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=353168"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/353168\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=353168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=353168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=353168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}